Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
To the Editor, While the outcomes of acute lymphoblastic leukemia (ALL) treatment in young children are excellent with > 90% long-term event-free survival (EFS) [1], outcomes among adults have continued to lag behind. Even with the utilization of pediatric-inspired chemotherapy (PIC) regimens, there remains a significant unmet need for 25%–40% of adult ALL patients who are not cured with upfront chemotherapy [2, 3].
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
